SHE:002581 Revenue

In the year 2024, Shandong Sinobioway Biomedicine had annual revenue of 360.41M CNY, down -16.14%. Shandong Sinobioway Biomedicine had revenue of 45.69M in the quarter ending December 31, 2024, a decrease of -50.03%.

Revenue

360.41M

Revenue Growth

-16.14%

P/S Ratio

15.08

Revenue / Employee

710.86K

Employees

507

Market Cap

5.44B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	360.41M	-69.39M	-16.14%
Dec 31, 2023	429.79M	72.71M	20.36%
Jan 1, 2023	357.08M	-45.63M	-11.33%
Jan 1, 2022	402.71M	125.88M	45.47%
Dec 31, 2020	276.83M	-290.81M	-51.23%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	27.98B
Shenzhen Mindray Bio-Medical Electronics	37.11B
WuXi AppTec	37.92B
Zhangzhou Pientzehuang Pharmaceutical.,	10.91B
Aier Eye Hospital Group	20.62B
Sichuan Biokin Pharmaceutical	5.82B
Yunnan Baiyao Group Co.,Ltd	40.03B
Shanghai United Imaging Healthcare	10.30B

Revenue Rankings